Bivalent mRNA vaccine effectiveness against COVID-19 infections, hospitalisations and deaths in Portugal: a cohort study based on electronic health records, September 2022 to May 2023
View ORCID ProfileAusenda Machado, View ORCID ProfileIrina Kislaya, View ORCID ProfilePatricia Soares, Sarah Magalhães, View ORCID ProfileAna Paula Rodrigues, Rafael Franco, Pedro Pinto Leite, Carlos Matias Dias, View ORCID ProfileBaltazar Nunes
doi: https://doi.org/10.1101/2023.09.05.23295025
Ausenda Machado
aInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
bCentro de Investigação em Saúde Pública, Universidade NOVA de Lisboa, Lisbon, Portugal
Irina Kislaya
aInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
Patricia Soares
aInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
bCentro de Investigação em Saúde Pública, Universidade NOVA de Lisboa, Lisbon, Portugal
Sarah Magalhães
cServiços Partilhados do Ministério da Saúde, Lisbon, Portugal
Ana Paula Rodrigues
aInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
Rafael Franco
cServiços Partilhados do Ministério da Saúde, Lisbon, Portugal
Pedro Pinto Leite
dDireção-Geral da Saúde, Lisbon, Portugal
Carlos Matias Dias
aInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
bCentro de Investigação em Saúde Pública, Universidade NOVA de Lisboa, Lisbon, Portugal
Baltazar Nunes
aInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
bCentro de Investigação em Saúde Pública, Universidade NOVA de Lisboa, Lisbon, Portugal
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data supporting the findings presented were obtained from population registries that belong to the General Directorate for Health (DGS), Central Administration of the Health System (ACSS) and Shared Services of the Ministry of Health (SPMS). The data has sensitive information and was licensed for exclusive use in the current study. Due to privacy regulations, the data is not openly available.
Posted September 05, 2023.
Bivalent mRNA vaccine effectiveness against COVID-19 infections, hospitalisations and deaths in Portugal: a cohort study based on electronic health records, September 2022 to May 2023
Ausenda Machado, Irina Kislaya, Patricia Soares, Sarah Magalhães, Ana Paula Rodrigues, Rafael Franco, Pedro Pinto Leite, Carlos Matias Dias, Baltazar Nunes
medRxiv 2023.09.05.23295025; doi: https://doi.org/10.1101/2023.09.05.23295025
Bivalent mRNA vaccine effectiveness against COVID-19 infections, hospitalisations and deaths in Portugal: a cohort study based on electronic health records, September 2022 to May 2023
Ausenda Machado, Irina Kislaya, Patricia Soares, Sarah Magalhães, Ana Paula Rodrigues, Rafael Franco, Pedro Pinto Leite, Carlos Matias Dias, Baltazar Nunes
medRxiv 2023.09.05.23295025; doi: https://doi.org/10.1101/2023.09.05.23295025
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2661)
- Dermatology (224)
- Emergency Medicine (402)
- Epidemiology (12264)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2670)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (441)
- Neurology (3912)
- Nursing (210)
- Nutrition (582)
- Oncology (2048)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (455)
- Public and Global Health (6551)
- Radiology and Imaging (1410)
- Respiratory Medicine (872)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)